Share Name Share Symbol Market Type Share ISIN Share Description
Biocare LSE:BSN London Ordinary Share GB00B1528F83 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.00p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services - - - - 0.34

Biocare (BSN) Latest News

Real-Time news about Biocare (London Stock Exchange): 0 recent articles
More Biocare News
Biocare Takeover Rumours

Biocare (BSN) Share Charts

1 Year Biocare Chart

1 Year Biocare Chart

1 Month Biocare Chart

1 Month Biocare Chart

Intraday Biocare Chart

Intraday Biocare Chart

Biocare (BSN) Discussions and Chat

Biocare Forums and Chat

Date Time Title Posts
16/2/200922:33*** BIOCARE SOLUTIONS***128
16/10/200822:37BSN 50% Upside This Week - Dont Blink.229
25/4/200815:46BSN with Charts & News1
06/6/200114:55BRIGHT STATION - "fall is overdone" says ABN Amro129

Add a New Thread

Biocare (BSN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Biocare trades in real-time

Biocare (BSN) Top Chat Posts

Biocare Daily Update: Biocare is listed in the Software & Computer Services sector of the London Stock Exchange with ticker BSN. The last closing price for Biocare was 1p.
Biocare has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 33,587,094 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Biocare is £335,870.94.
collijo: Further to the above maybe Tiptree has a point re the share price moving up. Looking at the small cap sector in particular Marchpole Holdings today issued a statement re fundraising and loan notes similar to BSN and the share price has risen on the back of it. It gives some hope to all holders...
tiredoldbroker: Tiptree, can't imagine why you think the share price will go up when the quote comes back. The company is effectively bust unless it gets this new injection of funds; and as I was saying on the previous thread to this, on that basis, anyone who puts up more capital is going to want shares issued at a fraction of a penny, diluting the existing shareholders down to almost nothing.
tiredoldbroker: Well, the share price is telling you that the market reckons the director who bought stock got it fundamentally wrong, and that the company has very major problems. RAB may feel that having gone this far, they might as well see it through, and bear in mind that their loans are secured on the assets of the company and its subsidiaries - so they can walk away with the business anyhow, and leave the other shareholdes with nothing. The basic problem is that BSN didn't raise enough cash at the start to get the project off the ground; as a result, they are now at their weakest just when they might hope to be launching. I'd advise you to look at what usually happens to companies in this sort of bind - like Danka, Bella Media or Paros, for example, where if there's an asset potentially worth having, someone else prizes it away because they can finance it, and the shareholders get nothing. Look at the cost of funding and that blunt statement - "unlikely that the Company would have sufficient working capital". It means they are in a parlous state and are operating on a knife edge, and indeed, if they do see growing demand for their products, they probably don't have the money to finance the stock needed, and could go bust trying. They've spent the money they had, it's all being done on borrowed cash now, and they probably can't raise any more beyond what they currently have. No equity left. Which is why the share price is at its current level. Sure, a couple of determined rampers could probably make the share price double from this level, if they could spin it to enough suckers, but I doubt very much that there's anything left in this for existing shareholders.
paddywak1967: It's possible but the company don't appear to be in trouble from an operational point of view. They just need capital to expand operations. If anything, they appear to have too much work and not enough capacity to sustain the work they are getting.....hence the new plant! If they issue a statement stating operations are going as planned then the share price will rise substantially. If they do not then it could well drop. Simple logic really!
paddywak1967: The money raised was not to service debt but to allow the company to expand substantially. This is from an RNS in April 07 LONDON (Thomson Financial) - Biocare Solutions PLC said production at its new facility in Ferrandina, Italy, will now begin in May, later than previously announced, but the development stays on budget. In February, the company had said it expects full production at the Ferrandina facility at end-March. It added that its existing plant in Meda (5040.KL - news) , Italy, is being run on double shifts to cope with the production shortfall. 'Once Ferrandina is commissioned, the plant will be capable of more than trebling throughput,' The worry is that the company have not said anything and let the share price plunge. On the plus side you have directors buying only 2 months ago at 5p.
superpete: Spear: There are no guarantees in life.You pays your money and makes your choice.Shares go up and down.Shares can trade above or below their true worth.Some investments are a higher risk compared to others but rewards could be higher.You can make or lose money.Companies can go bust and you lose the lot.All about timing, risk to reward. BSN,DANK,ATN,QXL,SCO,RED all fallen from great heights and speculative punt/gamble on how they trade and IF/how long they take to recover. Generally non profit making companies with cash burn and financing problems are bad news for investors.Things can go from bad to worse before they get better;or bust. Look at the number of Institutions that have taken up share placings/rights only to see the share price plummet.I've had my fingers burned in the past so I should know. The whole market is currently in downtrend and volatile. My view is that there is a possibility that BSN could fall below 5p.It is also possible to have sucker rallies where share prices manipulated to rise much higher only to fall twice as fast. Who knows? BSN is speculative and not without risk.Investors must imho make informed choices and as i have said previously 'go in with their eyes open'.Be careful.imho,dyor.
haystack: They are issuing more shares than there are at the monent. That means that your shareholding is being diluted to about 39% of it's previous share. You have the chance to buy 4 for 5 with new money at 5p. The share price is dropping to match the offer price or lower. The real question is what are the shares going to be worth after the dust settles. How long is the money going to last them and will they get new customers fast enough before the money dries up. I wonder how many BSN shareholders will cough up more money.
superpete: BSN now trading bid 7.5p offer 8.5p.This share does not come without some risks imho, even at these lowly levels.The placing of the 270m shares could in my view lower share price to say 6p/7p others may say 5p/6p or less. Investors can be encouraged or sucked in to trading a share higher only to see it fall back.That's the gamble-for novice investors be careful and if you punt on this one go in with your eyes open.More likely to lose.You either make or lose money on this one, which will take some time to throw off the title "Dial-a-Dog" whatever they re-name themselves.Personal views,imho,dyor etc.
shols: It seems to me that there are 2 questions to be answered,which are:- No.1)-If they get the finance they need,will they be a viable concern? No.2)-Will they get the finance? The answer to No.1 has to be yes,thanks to SmartLogic. With regard to No.2,CFSB have apparently agreed finance subject to the company having a market value of #30,000,000,which it currently does'nt have.But surely the main reason for the fall in market value is the concern over whether they will get their finance.Once finance has been arranged the share price and the market value should improve quite dramatically.Consequently I do not believe the current share price will have any detrimental effect on a decision to grant finance.
raging bull1: you have missed your chance old chap better have a look at the rns news x 3 of circa 1800 tonight looks to me as if bsn are getting it together and quickly to on the sort of news posted i would expect a rise in the share price from here starting tomorrow and when yes when the refinancing package is organised for sl/webtop then expect the share price to move back towards the 20p mark quickly also good posibility that dw will purchase sparza with his remaining bsn stock holding before driving off into the sunset. otherwise sparza closes thus reducing cash burn considerably regards tim
Biocare share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161025 22:45:08